论文部分内容阅读
自1995年以来应用重组α-干扰素（美国干扰能、立陶宛α-2b、中外合资α－1赛若金）治疗丙型肝炎39例，疗程为24周，疗程结束后完全应答者28例，部分应答者8例，无应答者3例。对完全应答者28例随访1年以上，每3个月化验肝功、丙肝病毒核糖核酸（HCVRNA），从而进一步观察评价干
Since 1995, 39 cases of hepatitis C were treated with recombinant α-interferon (U.S. interference energy, Lithuania α-2b, Sino-foreign joint venture Alpha-1 saujingen) for 24 weeks. Since the end of treatment, 28 cases were completely responders, Some respondents in 8 cases, 3 non-responders. 28 cases of complete responders were followed up for more than 1 year, liver function test every 3 months, hepatitis C virus RNA (HCVRNA), so as to further observe the evaluation of dry